-
Multimodal Genomic Features Predict Outcome of Immune Checkpoint Blockade in Non-small Cell Lung Cancer
Study
EGAS00001003892
-
Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade
Study
EGAS00001004353
-
Accumulation of copy number alterations and clinical progression across advanced prostate cancer
Study
EGAS00001006251
-
Therapy-Induced APOBEC3A Drives Evolution of Resistance to Targeted Therapies in Non-Small Cell Lung Cancer
Study
phs003256
-
Constitutional and somatic genomic rearrangements coherently restructure chromosome 21 in acute lymphoblastic leukaemia
Dataset
EGAD00001000658
-
Natural history of clonal haematopoiesis (2017-09-04)
Dataset
EGAD00001003703
-
Spiradenocarcinoma (2018-10-29)
Dataset
EGAD00001004426
-
pancreatic ductal adenocarcinoma exomes in study: Pro-immunogenic Impact of MEK inhibition combined with an anti-CD40 immunostimulatory antibody
Dataset
EGAD00001005938
-
ANGIOPREDICT - an FP7-funded project enabling personalised medicine for patients with metastatic colorectal cancer.
Dataset
EGAD00001008463
-
Mult-omics Palbociclib Resistance Study in HR+/HER2– Metastatic Breast Cancer
Study
EGAS00001005736